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
agent
Decreased neuronal activity in the nucleus basalis of Meynert in Alzheimer's disease as suggested by the size of the Golgi apparatusDecreased neuronal activity and therapeutic strategies directed towards reactivation in Alzheimer's diseaseNeurotrophin receptors in Alzheimer's diseaseSex- and age-related P75 neurotrophin receptor expression in the human supraoptic nucleusActivity of hippocampal CA1 neurons in Alzheimer's disease is not affected by the presence of adjacent neuritic plaquesMolecular misreading: a new type of transcript mutation expressed during agingEarly cytoskeletal changes as shown by Alz-50 are not accompanied by decreased neuronal activityLimited effect of senile plaques on neuronal density in the hippocampal CA1 Area of Alzheimer patientsBrain Banking in Aging and Dementia Research - The Amsterdam ExperienceAlzheimer's disease and NGF signallingP75 neurotrophin receptor in the nucleus basalis of Meynert in relation to age, sex and Alzheimer's diseaseLetter to the EditorColocalization of high affinity neurotrophin receptors in nucleus basalis of Meynert neurons and their differential reduction in Alzheimer's diseaseIncreased expression of the TIAR protein in the hippocampus of Alzheimer patientsA sex difference and no effect of ApoE-type on the amount of cytoskeletal alterations in the nucleus basalis of Meynert in Alzheimer's diseaseReduced neuronal activity and reactivation in Alzheimer's diseaseNeuronal atrophy, not cell death, is the main hallmark of Alzheimer's diseaseNeuropeptides vasopressin (AVP), oxytocin (OXT) and corticotropin-releasing hormone (CRH) in the human hypothalamus: activity changes in aging, Alzheimer's disease and depressionDecreased protein synthetic activity of the hypothalamic tuberomammillary nucleus in Alzheimer's disease as suggested by a smaller Golgi apparatusNeuronal activity and genetic background in Alzheimer's diseaseActivity of vasopressinergic neurons of the human supraoptic nucleus is age and sex dependentReduced neuronal activity is one of the major hallmarks of Alzheimer's diseaseDiminished neuronal metabolic activity in Alzheimer's diseaseCells in human post-mortem brain tissue slices remain alive for several weeks in cultureActivation of vasopressin neurons in aging and Alzheimer's diseaseControls are what makes a brain bank go roundDecreased activity of hippocampal neurons in Alzheimer's disease is not related to the presence of neurofibrillary tanglesAggravated activity of nucleus basalis neurons in Alzheimer's disease is ApoE type dependent